 | • レポートコード：B-MOR-040921 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、3D細胞培養の世界市場について調べ、3D細胞培養の世界規模、市場動向、市場環境、技術別（細胞がいマトリクス（足場）、バイオリアクター、ゲル、足場フリープラットフォーム、マイクロチップ、その他）分析、用途別（研究、創薬、組織工学、臨床、幹細胞研究、その他）分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・3D細胞培養の世界市場インサイト ・3D細胞培養の世界市場環境 ・3D細胞培養の世界市場動向 ・3D細胞培養の世界市場規模 ・3D細胞培養の世界市場規模：技術別（細胞がいマトリクス（足場）、バイオリアクター、ゲル、足場フリープラットフォーム、マイクロチップ、その他） ・3D細胞培養の世界市場規模：用途別（研究、創薬、組織工学、臨床、幹細胞研究、その他） ・3D細胞培養の世界市場規模：エンドユーザー別 ・3D細胞培養の世界市場：地域別市場規模・分析 ・3D細胞培養の北米市場規模・予測 ・3D細胞培養のアメリカ市場規模・予測 ・3D細胞培養のヨーロッパ市場規模・予測 ・3D細胞培養のアジア市場規模・予測 ・3D細胞培養の日本市場規模・予測 ・3D細胞培養の中国市場規模・予測 ・3D細胞培養のインド市場規模・予測 ・3D細胞培養の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global 3D Cell Culture market has been estimated to reach USD 682.8 million in 2017. The market is expected to register a CAGR of 20.3% during the forecast period, 2018 to 2023. North America dominates the market due to the incidence of cancer, and availability of well-established pharmaceutical and biotechnology industries.
Rising Need for Organ Transplantation
Cell culture is a process to grow prokaryotic cells or eukaryotic cells artificially, outside their natural environment, in a laboratory under controlled conditions. During the last decade, the demand for organ transplantation has increased, worldwide, due to increased incidences of organ failure, rise in success and improvement in post-transplant outcome. Increasing healthcare costs, aging population and rising prevalence of chronic disease that will continue to shape the industrial life science and thus majority of life science companies are investing in R&D sector.
Additionally, development of automated large-scale cell culture systems, use of 3D cell culture models, as an alternative tool in vivo testing and increasing focus on the regenerative medicine is also acting as a driver for Global 3D Cell Culture Market.
Budget Restriction for Small and Medium Sized Laboratories
3D hydrogels in cell culture market face challenges that have been hindering the market growth over the years. There hindrances include financial challenges by small & medium biotechnology and pharmaceutical companies. The initial investment, associated with 3D hydrogels in cell culture, is high. Moreover, organizations, operating at small or medium scale, are unable to bear the expenditure. This factor is the major restraint to the market growth. The application in developing countries of new biotechnology in cell culture and others areas will result in demand of experienced and skilled professionals and thus lack of skilled professionals for the 3D cell culture is also restraining the growth of 3D Cell Culture Market.
In addition, lack of consistency in 3D Cell Culture Products and Stringent Process Controls for advanced handling capabilities is also hindering the market.
North America to Dominate the Market
The market has been segmented on the basis of technology, application, end-user, and geography. Based on technology, the market has been segmented into extracellular matrices (scaffolds), bioreactors, gels, scaffold-free platforms, microchips, and others. The market, based on application, has been divided into research, drug discovery, tissue engineering, clinical applications, stem cell biology, and others. On the basis of end user, the market has been segregated into research laboratories and institutes, biotechnology and pharmaceutical industries, hospitals and diagnostic centers, and others. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the 3D Cell Culture market due to the due to the incidence of cancer, and availability of well-established pharmaceutical and biotechnology industries which are investing in the R&D projects carried out which results in the high demand in that region.
Key Developments in the Market
• October 2017: A partnership between Insphero AG and Charles River Laboratories International Inc.
• May 2017: 3D Biotek got FDA approval for 3D Cell Expansion System (3D-CES) as a medical device.
Key Players: 3D BIOMATRIX, REINNERVATE LTD, 3D BIOTEK LLC, BECTON DICKINSON AND COMPANY, SIGMA ALDRICH CORPORATION, CORNING INCORPORATED, THERMO FISHER SCIENTIFIC, GLOBAL CELL SOLUTIONS INC., NANOFIBER SOLUTIONS INCORPORATION, INSPHERO AG, LONZA GROUP, NANO 3D BIOSCIENCES.
REASONS TO PURCHASE THIS REPORT
• Current and future Global 3D Cell Culture Market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
CUSTOMIZATION OF THE REPORT
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次TABLE OF CONTENTS
1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTERS FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 HUGE INVESTMENT BY LIFE SCIENCE COMPANIES FOR R&D
6.1.2 DEVELOPMENT OF AUTOMATED LARGE-SCALE CELL CULTURE SYSTEMS
6.1.3 RISE IN RESEARCH AND DEVELOPMENT INVESTMENTS
6.1.4 RISING NEED FOR ORGAN TRANSPLANTATION
6.1.5 USE OF 3D CELL CULTURE MODELS AS AN ALTERNATIVE TOOL FOR INVIVO TESTING
6.1.6 INCREASING FOCUS ON REGENERATIVE MEDICINE
6.2 MARKET RESTRAINT
6.2.1 LACK OF EXPERIENCED AND SKILLED PROFESSIONALS
6.2.2 BUDGET RESTRICTION FOR SMALL AND MEDIUM SIZED LABORATORIES
6.2.3 LACK OF CONSISTENCY IN 3D CELL CULTURE PRODUCTS
6.2.4 STRINGENT PROCESS CONTROLS FOR ADVANCED HANDLING CAPABILITIES
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 BY TECHNOLOGY
7.1.1 EXTRACELLULAR MATRICES (SCAFFOLDS)
7.1.2 BIOREACTORS
7.1.3 GELS
7.1.4 SCAFFOLD-FREE PLATFORMS
7.1.5 MICROCHIPS
7.1.6 OTHERS
7.2 BY APPLICATION
7.2.1 RESEARCH
7.2.2 DRUG DISCOVERY
7.2.3 TISSUE ENGINEERING
7.2.4 CLINICAL APPLICATIONS
7.2.5 STEM CELL BIOLOGY
7.2.6 OTHERS
7.3 BY END USER
7.3.1 RESEARCH LABORATORIES AND INSTITUTES
7.3.2 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
7.3.3 HOSPITALS AND DIAGNOSTIC CENTERS
7.3.4 OTHERS
7.4 SEGEMENTATION BY GEOGRAPHY
7.4.1 NORTH AMERICA
7.4.1.1 UNITED STATES
7.4.1.2 CANADA
7.4.1.3 MEXICO
7.4.2 EUROPE
7.4.2.1 FRANCE
7.4.2.2 GERMANY
7.4.2.3 UNITED KINGDOM
7.4.2.4 ITALY
7.4.2.5 SPAIN
7.4.2.6 REST OF EUROPE
7.4.3 ASIA-PACIFIC
7.4.3.1 CHINA
7.4.3.2 JAPAN
7.4.3.3 INDIA
7.4.3.4 AUSTRALIA & NEW ZEALAND
7.4.3.5 SOUTH KOREA
7.4.3.6 REST OF ASIA-PACIFIC
7.4.4 MIDDLE EAST AND AFRICA
7.4.4.1 GCC
7.4.4.2 SOUTH AFRICA
7.4.4.3 REST OF MIDDLE EAST AND AFRICA
7.4.5 SOUTH AMERICA
7.4.5.1 BRAZIL
7.4.5.2 ARGENTINA
7.4.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS & PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. COMPANY PROFILES
9.1 3D BIOMATRIX
9.2 REINNERVATE LTD
9.3 3D BIOTEK LLC
9.4 BECTON DICKINSON AND COMPANY
9.5 SIGMA ALDRICH CORPORATION
9.6 CORNING INCORPORATED
9.7 THERMO FISHER SCIENTIFIC
9.8 GLOBAL CELL SOLUTIONS INC
9.9 NANOFIBER SOLUTIONS INCORPORATION
9.10 INSPHERO AG
9.11 LONZA GROUP
9.12 NANO 3D BIOSCIENCES
10. FUTURE OUTLOOK OF THE MARKET